Outcomes for Patients With Chronic Lymphocytic Leukemia (CLL) Previously Treated With Both a Covalent BTK and BCL2 Inhibitor in the United States: A Real-World Database Study-Reference-Cited by-同舟云学术

Outcomes for Patients With Chronic Lymphocytic Leukemia (CLL) Previously Treated With Both a Covalent BTK and BCL2 Inhibitor in the United States: A Real-World Database Study

Published:2023-01 Issue:1 Volume:23 Page:57-67
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Mato Anthony R.,Hess Lisa M.^ORCID,Chen Yongmei,Abada Paolo B.,Konig Heiko,Pagel John M.,Walgren Richard A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference18 articles.

1. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021

2. Chronic lymphocytic leukemia treatment algorithm 2018;Parikh;Blood Cancer J,2018

3. Treatment of elderly patients with chronic lymphocytic leukemia;Eichhorst;Leukemia & lymphoma,2009

4. NCCN Clinical Practice Guidelines in Oncology: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2022, available at www.nccn.org. Accessed January 20, 2022,2022

5. Chemotherapy-free frontline therapy for CLL: is it worth it?. Hematology 2014;Rhodes;Am Soc Hematol Educ Program Book,2020

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia;Annals of Oncology;2024-09

2. Real‐world comparative effectiveness of venetoclax‐obinutuzumab versus Bruton tyrosine kinase inhibitors for frontline chronic lymphocytic leukaemia;British Journal of Haematology;2024-07-24

3. Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunities;HemaSphere;2024-07

4. Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed;Cancers;2024-05-25

5. Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal study;Leukemia & Lymphoma;2024-05-02